To determine whether the β-blocker carvedilol reduces the incidence of atrial or ventricular arrhythmias in post-MI patients receiving ACE inhibitors. This was a substudy of the multinational ...

However, it has been found that additional α-adrenergic blockade with carvedilol may increase the number of patients with hemodynamic responses resulting in a reduction in hepatic venous pressure ...

a carvedilol phosphate extended-release capsule for heart failure and hypertension; and Ranexa, a ranolazine extended release tablet for chronic angina. Further, the company is developing ...